Anavar (Oxandrolone) 10mg is a low dose oral anabolic tablet formulation supplied in a 50 tablet pack. Manufactured for consistent potency, stability, and research applications.
Format50 Tablets
Concentration10mg
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Oxandrolone, widely known by its pharmaceutical brand name Anavar, is a synthetic anabolic compound derived from dihydrotestosterone (DHT) with an extensive clinical history distinguishing it from most oral anabolic research compounds. Originally developed in the 1960s and clinically approved for treating muscle wasting, weight loss associated with chronic illness, bone pain from osteoporosis, and recovery from severe burns, Oxandrolone carries one of the broadest legitimate pharmaceutical application histories of any oral anabolic compound, contributing to a clinical literature base that remains actively referenced in contemporary research. F40 Biotech’s formulation delivers 10mg per tablet in a 50 count format, a low dose precision presentation well suited to titration based research protocols.
Oxandrolone’s pharmacological profile is defined by several characteristics that distinguish it within the oral anabolic compound family. As a DHT derived compound it does not aromatize under any circumstances, producing no estrogenic conversion regardless of dose. Despite being 17 alpha alkylated for oral bioavailability, Oxandrolone is consistently documented as carrying a significantly milder hepatotoxicity profile than most other alkylated oral anabolic compounds; a characteristic attributed to its primary excretion via the kidneys rather than the liver, an unusual metabolic pathway that makes it one of the few oral anabolic steroids where hepatic stress marker elevation is documented as comparatively minimal in research subjects.
At 10mg per tablet this formulation provides precise low dose titration capability across research protocols examining dose response relationships at the lower end of the Oxandrolone concentration range. The 10mg unit dose is particularly well referenced in clinical literature examining Oxandrolone’s applications in female subjects, pediatric research, and elderly populations. Research contexts where the compound’s mild androgenic profile and comparatively favorable safety documentation have made it the most frequently studied oral anabolic compound across sensitive population groups.
F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s Oxandrolone meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store in a cool, dry place away from direct light and heat. Intended for research purposes only.
Commonly researched alongside testosterone base compounds in comparative mild anabolic activity studies. Browse CSD’s full oral range and PCT compounds for complete protocol sourcing.
The active compound is identical; Oxandrolone but the 10mg tablet allows significantly more precise dose titration than the 25mg version. Researchers targeting conservative starting doses of 10–20mg daily can achieve exact doses with 10mg tablets without requiring tablet splitting. The 10mg dose is particularly relevant for female anabolic research where conservative doses of 5–10mg daily are most commonly studied to minimize virilization risk, and for male researchers beginning Anavar protocols at lower doses before titrating upward. The 10mg tablet is also the most common pharmaceutical Anavar tablet dose, matching original Searle and BTG pharmaceutical formulations.
Anavar (Oxandrolone) is a 17-alpha alkylated DHT derivative with a high anabolic to androgenic ratio and one of the broadest clinical research histories of any oral anabolic compound. Originally developed by Searle Laboratories, it has been studied extensively for muscle wasting, weight restoration following surgery or infection, osteoporosis, Turner syndrome, and burn recovery research. In performance research contexts it is studied for lean mass preservation and accretion, strength enhancement, fat loss, and bone density improvement; with a significantly milder hepatotoxicity and androgenic side effect profile compared to most other oral anabolic compounds.
Yes, the 10mg tablet dose is the most commonly researched Anavar dose for female subjects. Oxandrolone is one of the few anabolic compounds studied in female research contexts due to its low virilization risk at conservative doses. Common female research doses range from 5–10mg daily, achievable with one 10mg tablet or half a tablet for 5mg dosing. Research protocols for female subjects typically run 4–6 weeks in duration at these doses with monitoring for early virilization signs. The 10mg tablet format is significantly more practical for female research protocols than 25mg or 50mg tablets which would require splitting to achieve appropriate doses.
Oxandrolone has a half-life of approximately 8–10 hours typically administered in two divided daily doses for stable plasma levels. For male research protocols, common daily doses range from 40–80mg (4–8 tablets) split morning and afternoon. For female research protocols, 5–10mg daily (half to one tablet) is the most studied dose range. The 50 tablet pack at 10mg provides 500mg total; sufficient for 6–12 days of male research at 40–80mg daily, or 50–100 days of female research at 5–10mg daily.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 10mg per tablet and compound identity as Oxandrolone. A certificate of analysis is available.
